MedTrace Logo

Evaluation of Inflammatory Markers in LARC Patients

NCT05893667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 245

Last updated 2023-06-12

No results posted yet for this study

Summary

Introduction: In locally advanced rectal cancers (LARC), TNM staging is far from optimal. We aimed to investigate the value of previously described circulating biomarkers as predictors of prognosis.

Methods: Retrospective analysis of 245 LARC patients diagnosed between January 2010 and December 2022, who underwent neoadjuvant chemoradiotherapy and surgery at two centers. A Cox regression and Kaplan-Meier analysis were performed.

Conditions

  • Locally Advanced Rectal Cancer

Interventions

DIAGNOSTIC_TEST

Inflammatory markers

analysis of inflammatory scores

Sponsors & Collaborators

  • Hospital Pedro Hispano

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2022-12-01
Completion
2023-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05893667 on ClinicalTrials.gov